Pristane induces autophagy in macrophages, promoting a STAT1-IRF1-TLR3 pathway and arthritis

Clin Immunol. 2017 Feb:175:56-68. doi: 10.1016/j.clim.2016.11.017. Epub 2016 Dec 7.

Abstract

Autophagy is involved in both innate and adaptive immune regulation. We propose that autophagy regulates activation of TLR3 in macrophages and is thereby essential for development of pristane-induced arthritis. We found that pristane treatment induced autophagy in macrophages in vitro and in vivo, in spleen cells from pristane injected rats. The induced autophagy was associated with STAT1 phosphorylation and expression of IRF1 and TLR3. Blocking the pristane activated autophagy by Wortmannin and Bafilomycin A1 or by RNAi of Becn1 led to a downregulation of the associated STAT1-IRF1-TLR3 pathway. Most importantly, the development of arthritis was alleviated by suppressing either autophagy or TLR3. We conclude that pristane enhanced autophagy, leading to a STAT1-IRF1 controlled upregulation of TLR3 expression in macrophages, is a pathogenic mechanism in the development of arthritis.

Keywords: Autophagy; Experimental arthritis; Gene expression; Macrophages; TLR3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arthritis, Experimental / drug therapy*
  • Arthritis, Experimental / metabolism
  • Autophagy / drug effects*
  • Down-Regulation / drug effects
  • Interferon Regulatory Factor-1 / metabolism*
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Phosphorylation / drug effects
  • Rats
  • STAT1 Transcription Factor / metabolism*
  • Signal Transduction / drug effects
  • Terpenes / pharmacology*
  • Toll-Like Receptor 3 / metabolism*
  • Up-Regulation / drug effects

Substances

  • Interferon Regulatory Factor-1
  • Irf1 protein, rat
  • STAT1 Transcription Factor
  • Stat1 protein, rat
  • TLR3 protein, rat
  • Terpenes
  • Toll-Like Receptor 3
  • pristane